Today: 19 May 2026
Browse Category

NYSE:PHM 29 December 2025 - 5 May 2026

Netflix’s $25 Billion Buyback Looks Big. Microsoft’s $190 Billion AI Capex Bill Looks Bigger

Netflix’s $25 Billion Buyback Looks Big. Microsoft’s $190 Billion AI Capex Bill Looks Bigger

Netflix’s board approved an extra $25 billion in share buybacks after the company ended talks to buy Warner Bros Discovery assets and received a $2.8 billion breakup fee. On Tuesday, Netflix shares fell 2.3% to $88.89, while Microsoft dropped 0.8% and PulteGroup rose 2.6%. Microsoft plans $190 billion in AI and cloud spending this year. PulteGroup and Mobileye also expanded buybacks following stock declines.
5 May 2026
······
Mortgage Rates Today: 30-Year Loan Holds Near 2026 Highs as Homebuilder Stocks Rebound

Mortgage Rates Today: 30-Year Loan Holds Near 2026 Highs as Homebuilder Stocks Rebound

U.S. 30-year fixed mortgage rates slipped to 6.49% Monday, down 0.04 percentage point, according to Mortgage News Daily, while Freddie Mac’s latest weekly survey held at 6.22%. New-home sales fell 17.6% in January to the lowest level since October 2022. Homebuilder stocks rose as oil prices dropped and bond yields eased after the U.S. postponed strikes on Iranian power plants.
23 March 2026
·····
Mortgage rates today drop below 6% — why housing stocks still can’t catch a break

Mortgage rates today drop below 6% — why housing stocks still can’t catch a break

Freddie Mac reported the average 30-year fixed mortgage rate fell to 5.98% this week, the first drop below 6% since 2022. Housing stocks slumped Wednesday, with Lennar down 4.9%, PulteGroup off 4.5%, and D.R. Horton losing 4%. The Nasdaq fell 1.5% Thursday as Nvidia shares declined. Mortgage News Daily’s daily index showed the 30-year rate steady at 6.00%.
26 February 2026
······
Mortgage rates today tick lower as U.S. markets shut; homebuilder stock prices in focus ahead of Fed minutes

Mortgage rates today tick lower as U.S. markets shut; homebuilder stock prices in focus ahead of Fed minutes

U.S. mortgage rates fell, with Bankrate reporting the average 30-year fixed at 6.13% on Feb. 16, down 10 basis points from last week. Stock markets were closed Monday for Presidents Day and will reopen Tuesday. Mortgage applications were flat, with more borrowers choosing FHA loans and ARMs. Retail sales and Fed minutes later this week are expected to influence rates.
16 February 2026
·····
Champion Homes stock jumps 12% on earnings, buyback refresh — what to watch next

Champion Homes stock jumps 12% on earnings, buyback refresh — what to watch next

Champion Homes shares surged 12.3% to $85.36 after reporting a 1.8% sales increase and an expanded $150 million buyback authorization. Net income fell 11.7% to $54.3 million, while backlog dropped 15.1% to $266 million. U.S. home sales slipped 2.6%, but average selling price rose 4.6% to $99,300. Other housing stocks also gained during the session.
4 February 2026
······
Mortgage rates today near 6% as Fed meeting kicks off; housing stocks mixed

Mortgage rates today near 6% as Fed meeting kicks off; housing stocks mixed

U.S. 30-year mortgage rates hovered near 6.1% early Tuesday, with Bankrate showing an average of 6.20% and Mortgage News Daily at 6.17%. The 10-year Treasury yield closed at 4.22%. Homebuilder shares slipped, with Lennar down 1.1% and the iShares U.S. Home Construction ETF off 0.6%. Investors await the Federal Reserve’s policy meeting for signals on future borrowing costs.
27 January 2026
·······
Mortgage rates today hold near 3-year lows as Fed meeting nears; homebuilder shares slip

Mortgage rates today hold near 3-year lows as Fed meeting nears; homebuilder shares slip

The average 30-year fixed mortgage rate holds near 6%, its lowest level in over three years, with Freddie Mac reporting 6.09% and Bankrate at 6.20%. Core PCE inflation remains above the Fed’s 2% target at 2.8%. Treasury yields and new inflation data are shaping rates ahead of the Federal Reserve’s meeting next week. Mortgage applications jumped 14.1% last week, according to the Mortgage Bankers Association.
23 January 2026
·····
D.R. Horton stock rises as KBW trims target — what Wall Street is watching next

D.R. Horton stock rises as KBW trims target — what Wall Street is watching next

D.R. Horton shares rose about 1% to $158.82 Monday afternoon, tracking gains in other major homebuilders. Keefe Bruyette & Woods cut its price target on the stock to $168 from $175 but kept a “Market Perform” rating. Investors are focused on D.R. Horton’s Jan. 20 earnings after the company warned that affordability pressures could keep sales incentives high in 2026.
12 January 2026
·····
Real Estate Stocks in focus: XLRE, REITs brace for CPI after Trump’s $200 billion mortgage-bond push

Real Estate Stocks in focus: XLRE, REITs brace for CPI after Trump’s $200 billion mortgage-bond push

U.S. housing stocks rallied Friday after the Trump administration launched a $200 billion mortgage-bond purchase program, with the Philadelphia Housing index jumping 4.8%. REIT-focused ETFs posted smaller gains. Treasury Secretary Scott Bessent said the first $3 billion in purchases has begun. Thirty-year mortgage rates remain near 6.2% as investors await Tuesday’s CPI report.
11 January 2026
···
Tri Pointe Homes stock jumps nearly 9% as Trump mortgage-bond order lifts homebuilders; CPI next

Tri Pointe Homes stock jumps nearly 9% as Trump mortgage-bond order lifts homebuilders; CPI next

Tri Pointe Homes shares rose 8.7% to $35.42 Friday after President Trump announced a $200 billion federal purchase of mortgage bonds aimed at lowering rates. Other homebuilder stocks also climbed. RBC Capital lowered its price target for Tri Pointe to $31, citing affordability concerns. December CPI data is due Tuesday.
11 January 2026
·····
Tri Pointe Homes stock jumps nearly 9% as mortgage-bond move lifts homebuilders; CPI is next

Tri Pointe Homes stock jumps nearly 9% as mortgage-bond move lifts homebuilders; CPI is next

Tri Pointe Homes shares surged 8.7% to $35.42 Friday after President Trump ordered $200 billion in mortgage-backed securities purchases to lower mortgage rates. Other homebuilder stocks also rallied. Freddie Mac reported the average 30-year fixed mortgage at 6.16% this week. Traders await Tuesday’s U.S. CPI report for the next move in rates.
11 January 2026
······
Lennar stock jumps nearly 9% on Trump’s $200 billion mortgage-bond push — what to watch next

Lennar stock jumps nearly 9% on Trump’s $200 billion mortgage-bond push — what to watch next

Lennar Corp surged 8.85% to $119.25 Friday, leading U.S. homebuilders higher after President Trump ordered $200 billion in mortgage bond purchases. Treasury Secretary Scott Bessent said the move aims to offset the Fed’s MBS roll-off. Analysts expect the plan to lower mortgage rates by 10–25 basis points. Wall Street questioned whether Fannie Mae and Freddie Mac will remain under government control.
11 January 2026
····
JPMorgan slashes KB Home target to $50 as Wall Street flags weaker 2026 returns

JPMorgan slashes KB Home target to $50 as Wall Street flags weaker 2026 returns

JPMorgan cut its KB Home price target to $50 from $71 and lowered 2026 and 2027 earnings estimates after the company’s fiscal Q4 report. KB Home’s 2026 return on equity is projected at 6%, down from 11% in 2025. Shares fell 0.3% to $57.16 in morning trading. Fiscal Q4 earnings per share dropped to $1.92 from $2.52 a year earlier, with revenue down 15.5% to $1.69 billion.
29 December 2025
······

Stock Market Today

  • Kinross Gold Stock Up 96% in One Year: Is It Still a Buy?
    May 19, 2026, 5:12 AM EDT. Kinross Gold (TSX:K) surged 96.4% over the past year but dipped 18.5% last month, closing at C$39.03. Despite this strong rally, a Discounted Cash Flow (DCF) analysis values the stock at C$47.53, implying it is trading at a 17.9% discount and could be undervalued. The DCF method projects future cash flows based on analyst estimates to determine intrinsic value. Kinross Gold's current price-to-earnings (P/E) ratio stands at 11.84, reflecting market sentiment on its profitability and risk. Analysts forecast steady free cash flow through 2030, supporting the bullish valuation. Investors reassessing commodity stocks might find Kinross Gold attractive despite recent volatility, as its fundamentals suggest continued value potential.

Latest articles

Evolution Stock Is Jumping—The €2 Billion Reason Investors Are Watching

Evolution Stock Is Jumping—The €2 Billion Reason Investors Are Watching

19 May 2026
Stockholm, May 19, 2026, 11:01 (CEST) Evolution AB shares jumped in Stockholm on Tuesday after the online casino technology group announced a €2 billion share buyback, giving investors a large and immediate capital-return story after months of concern over regulation and slowing European growth. The stock traded at 723.80 Swedish crowns at 10:51 a.m. local time, up 9.07%, after touching 746.60 crowns earlier in the session, according to Google Finance data. Evolution said late Monday that its board had resolved to start the buyback immediately. (Google) This matters now because the buyback, where a company purchases its own shares and
NextEra shares dip after $66.8B Dominion deal—What’s on traders’ radar now

NextEra shares dip after $66.8B Dominion deal—What’s on traders’ radar now

19 May 2026
NextEra Energy shares fell 4.6% to $89.04 late Monday after announcing a $66.8 billion stock-led merger with Dominion Energy, whose shares rose 9.4% to $67.56. The deal would create one of the world’s largest electric utilities, serving about 10 million customer accounts and owning 110 gigawatts of generation across four states.
Costco Stock Just Hit a High—Here’s the Next Thing Traders Are Watching

Costco Stock Just Hit a High—Here’s the Next Thing Traders Are Watching

19 May 2026
Costco shares closed Monday up 2.62% at $1,076.47, marking a fifth straight gain and outpacing Walmart and Target. April net sales rose 13% to $23.92 billion, with comparable sales up 11.6%. The company will report fiscal third-quarter earnings on May 28. Analysts’ average price target is $1,072.91, just below Monday’s close.

Popular

Regeneron stock sinks after cancer trial miss prompts selloff

Regeneron stock sinks after cancer trial miss prompts selloff

19 May 2026
Regeneron Pharmaceuticals shares fell 9.8% to $629.68 Monday after its late-stage melanoma drug trial with fianlimab failed to meet the main goal. The study did not show a statistically significant benefit over Merck’s Keytruda. At least 10 brokerages cut price targets. The decline outpaced broader market losses, with the Nasdaq down 0.5%.
Go toTop